Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
A Randomized Controlled Trial of Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
1 other identifier
interventional
44
1 country
1
Brief Summary
The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer prevention. While this procedure is currently performed during hysterectomies, its feasibility at the time of cesarean delivery is not well established. This randomized, prospective clinical trial will compare the two sterilization methods to demonstrate that salpingectomy compared with standard tubal ligation at the time of cesarean delivery will not result in increased operative time, blood loss or other complications. This study is necessary to promote salpingectomy as a standard sterilization method during cesarean deliveries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2017
CompletedFirst Posted
Study publicly available on registry
January 23, 2017
CompletedStudy Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2018
CompletedApril 10, 2018
April 1, 2018
10 months
January 13, 2017
April 7, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Time of tubal ligation
Primary outcome will be the time it takes to complete the sterilization procedure
at time of procedure
Secondary Outcomes (3)
Total procedure time
at time of procedure
Estimated blood loss
at time of procedure
Rate of aborted procedures
at time of procedure
Other Outcomes (3)
Reoperation rate
within 6 weeks
Length of stay
within 1008 hours
Readmission rate
within 6 weeks
Study Arms (2)
Control
OTHERTubal sterilization will be performed by standard tubal ligation, either Parkland or Pomeroy technique, at the time of cesarean section
Experimental
EXPERIMENTALTubal sterilization will be performed by bilateral salpingectomy using a ligasure device at the time of cesarean section.
Interventions
Bilateral salpingectomy will be performed instead of standard tubal ligation as sterilization during cesarean section.
Standard tubal ligation by either Parkland or Pomeroy technique will be performed at cesarean section
Eligibility Criteria
You may qualify if:
- Subjects must have planned cesarean delivery and desire sterilization
- Subjects must be able to read and provide written informed consent
- Subjects must be English or Spanish speaking
You may not qualify if:
- Subjects with known hereditary cancer syndromes
- Subjects with a history of prior tubal surgery
- Subjects with a placenta accreta
- Subjects undergoing trial of labor after cesarean delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22908, United States
Related Publications (1)
Garcia C, Moskowitz OM, Chisholm CA, Duska LR, Warren AL, Lyons GR, Pettit KE. Salpingectomy Compared With Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2018 Jul;132(1):29-34. doi: 10.1097/AOG.0000000000002674.
PMID: 29889755DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kate' Pettit, MD
University of Virginia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Division of Maternal Fetal Medicine
Study Record Dates
First Submitted
January 13, 2017
First Posted
January 23, 2017
Study Start
May 1, 2017
Primary Completion
March 5, 2018
Study Completion
March 5, 2018
Last Updated
April 10, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share